Darren Cunningham

CEO and Co-Founder

Dr Kathy Gately

Senior Scientist (Translational Oncology)

Frank Bonner

Head of Non-Clinical Safety

Shaun McNulty Ph.D.

Chief Scientific Officer

Paul Dickinson PhD

CMC: Preclinical and Clinical
Formulation Development

Gerry McGettigan

Regulatory Affairs

Tess Barker PhD

Head of Development

Dr. David Lathbury

CMC: Process Chemistry

Gemma Carroll

Financial Controller